Chemopreventive and anti-cancer properties of the aqueous extract of flowers of Butea monosperma

被引:53
作者
Choedon, Tenzin [1 ]
Shukla, Surendra Kumar [1 ]
Kumar, Vijay [1 ]
机构
[1] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India
关键词
Butea monosperma; HCC; HBx-transgenic mice; Plant extract; TUNEL assay; MAP kinase; TRANSGENIC MOUSE MODEL; HEPATOCELLULAR-CARCINOMA;
D O I
10.1016/j.jep.2010.03.011
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Butea monosperma (Lam.) (Fabaceae) popularly known as 'flame of the forest' has been widely used in the traditional Indian medical system of 'Ayurveda' for the treatment of a variety of ailments including liver disorders. Aim of the study: To evaluate the antioxidative, anti-inflammatory, hepatoprotective and anti-cancer activities of the aqueous extract of Butea monosperma flowers. Materials and methods: Dried flowers of Buten monosperma were extracted with water. The extract was tested for its anti-proliferative, pro-apoptotic and anti-carcinogenic effects in hepatoma cell lines. The chemopreventive and anti-angiogenic effects of the extract were evaluated by its daily oral administration in a HBV-related X15-myc mouse model of hepatocellular carcinoma (HCC). Results: Treatment with the aqueous extract inhibited cell proliferation and accumulation of cells in Cl phase. This was accompanied by a marked reduction in the levels of activated Erk1/2 and SAPK/JNK and induction of apoptotic cell death. Oral administration of the extract in transgenic mice conferred hepatoprotection as is evident from normal serum ALT levels and improved liver histopathology and lowered serum VEGF level. Conclusions: The ability of aqueous extract of Butea monosperma flowers to impose growth arrest and trigger pro-apoptotic death in cell culture strongly correlated with its strong chemopreventive effect in vivo when given orally. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:208 / 213
页数:6
相关论文
共 19 条
[1]  
Burli D. A., 2007, Pharmacognosy Reviews, V1, P333
[2]   Targeting the cell cycle for cancer therapy [J].
Carnero, A .
BRITISH JOURNAL OF CANCER, 2002, 87 (02) :129-133
[3]   Anticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma [J].
Choedon, Tenzin ;
Mathan, Ganeshan ;
Arya, Soneera ;
Kumar, Vijay L. ;
Kumar, Vijay .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (16) :2517-2522
[4]   Bioactive Flavonoids of the Flowers of Butea monosperma [J].
Chokchaisiri, Ratchanaporn ;
Suaisom, Channarong ;
Sriphota, Siriluk ;
Chindaduang, Anon ;
Chuprajob, Thipphawan ;
Suksamrarn, Apichart .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2009, 57 (04) :428-432
[5]   Mitochondrion as a novel target of anticancer chemotherapy [J].
Costantini, P ;
Jacotot, E ;
Decaudin, D ;
Kroemer, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (13) :1042-1053
[6]   Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab [J].
Finn, Richard S. ;
Zhu, Andrew X. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) :503-509
[7]  
Gurav S., 2008, IRAN J PHARM THER, V7, P21
[8]   MAPK signalling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutic benefits [J].
Kaminska, B .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2) :253-262
[9]   Vascular Endothelial Growth Factor in the Management of Hepatocellular Carcinoma A Review of Literature [J].
Kaseb, Ahmed O. ;
Hanbali, Amr ;
Cotant, Matthew ;
Hassan, Manal M. ;
Wollner, Ira ;
Philip, Philip A. .
CANCER, 2009, 115 (21) :4895-4906
[10]   Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: A sequential pathological evaluation [J].
Lakhtakia, R ;
Kumar, V ;
Reddi, H ;
Mathur, M ;
Dattagupta, S ;
Panda, SK .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (01) :80-91